Lucosky Brookman Successfully Represents EF Hutton in $8.0 Million Public Offering of Applied UV, Inc.
Lucosky Brookman congratulates its client, EF Hutton on its successful public offering of $8.0 million of common stock of Applied UV, Inc. (Nasdaq: AUVIP). Applied UV, Inc. is an industry leader in air and surface pathogen elimination technology. The Company announced the pricing of its underwritten public offering of 2,666,667 shares of common stock at a public offering price of $3.00 per share, for aggregate gross proceeds of approximately $8.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses.
Lucosky Brookman represented EF Hutton, a division of Benchmark Investments, LLC, in its capacity as sole book-running manager.
Applied UV is focuses on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company expects to use the net proceeds of this offering for general corporate purposes, including new investments and acquisitions.